{
    "title": "110_s2476",
    "content": "The \"Improved Vaccine Supply Act\" is cited as the short title. It amends the Public Health Service Act to include a new section on adequate vaccine supply. The Secretary will develop a plan for purchasing and storing a supply of vaccines for children and adults to cover recommended vaccinations for a 6-month period. The Secretary will develop a plan for purchasing and storing a supply of vaccines for children and adults to cover recommended vaccinations for a 6-month period, including all vaccines routinely recommended by the Advisory Committee on Immunization Practices for both children and adults. The Secretary's plan for purchasing and storing vaccines shall include all vaccines recommended for children and adults by the Advisory Committee on Immunization Practices, as well as other designated vaccines for public health preparedness efforts. The Secretary will carry out this plan using the authority provided under the Social Security Act. The Secretary will include designated vaccines for public health preparedness efforts, carrying out the plan using authority under the Social Security Act and other relevant laws. The Secretary will submit a plan developed under subsection (a) to specified Senate committees within 6 months of enactment, utilizing authority under the Social Security Act and other relevant laws. The Secretary will submit a plan to specified Senate committees within 6 months of enactment, detailing considerations and schedule prioritization. The Secretary will submit a plan to the House of Representatives Committee on Energy and Commerce, including considerations and schedule prioritization for vaccine purchases by September 30, 2008. The Secretary will implement the plan for purchasing vaccines by September 30, 2008. Manufacturers must provide 1 year notice of vaccine discontinuance to maintain the vaccine supply. The Secretary requires vaccine manufacturers to give at least 1 year notice of discontinuance to maintain the vaccine supply, with the option to reduce the notice period under certain conditions. The Secretary can reduce the notification period for vaccine discontinuance if good cause is certified, as per section 506C(b) of the Federal Food, Drug, and Cosmetic Act. Proceeds from vaccine sales will be used to purchase additional vaccines, with ongoing reports required. The Secretary can use proceeds from vaccine sales to buy more vaccines for the supply, with ongoing reports on plan implementation progress required. The Secretary must submit reports detailing progress and obstacles in implementing the plan developed, with a recommendation included in the first report. The Secretary must submit reports on progress and obstacles in implementing the plan, with a recommendation on extending the vaccine supply beyond the initial 6-month period. The Secretary must submit reports on progress and obstacles in implementing the plan, with a recommendation on extending the vaccine supply beyond the initial 6-month period. Authorization of appropriations is provided for fiscal years 2008 through 2012."
}